Sooooooo if I was KB I’d set a huge settlement price and
Sooooooo if I was KB I’d set a huge settlement price and hold up a 2 + billion dollar deal , time to f...... with them for awhile!
What usually occurs Grasshopper is the company in litigation files a second lawsuit to hold up the sale pending resolution of the first lawsuit claiming that J&J are evil doers and that Lifescan's OneTouch Ultra product provides almost all of the value of the corporation, and the technology in that product is stolen. That will set the stage for a settlement on the six years of commerce enjoyed by J&J pre-2016 (when the suit was filed by DECN), and a royalty going forward which I would guess to be 2-4% of net sales. These suits are called Strike Suits, and DECN's suit would not be the only suit filed. J&J are MFs and attempt to screw everyone. There will be a lot of anger involved with this merger.
The anger in this merger will make the anger displayed by the penny traders and the stock flips on the DECN message boards look amateurish in comparison.
3
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...
Continue Reading
Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...
Continue Reading
Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...
Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...
Continue Reading
Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...
Continue Reading